Erfo 1H26 operating income rises to EUR 771,101; revenue edges up to EUR 5.05 million

Bitget2026/09/29 07:49

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Laboratorio Farmaceutico Erfo posted 1H26 revenue of EUR 5.05 million, up 1% versus 1H25.
EBIT rose 4% to EUR 771,101, while result for the period edged down to EUR 456,624.
Medical Division revenue more than doubled to EUR 337,000, while Fit and Go contributed EUR 1.1 million, down 35%.
Net financial position improved to EUR 93,828 from EUR 328,579 at Dec. 31, 2025; the group reported 280 active points of sale.
Management said 2026 marks full operational integration and highlighted growth in the Medical Division and the French unit, plus initial cross-selling projects.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laboratorio Farmaceutico Erfo S.p.A. published the original content used to generate this news brief on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Erfo 1H26 operating income rises to EUR 771,101; revenue edges up to EUR 5.05 million

You may also like

Crypto prices